Andrologic studies, testosterone plasma level and chorionic gonadotropin loading in diabetics with potency disorders
Neubauer, M.; Demisch, K.; Schöffling, K.; Wiegelmann, W.; Solbach, H.G.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 1060-1063
1971
ISSN/ISBN: 0070-4067 PMID: 5155962 Document Number: 37100
Document emailed within 1 workday
Related Documents
Wiegelmann, W.; Solbach, H.G.; Neubauer, M.; Demisch, K.; Schöffling, K. 1971: FSH and ICSH plasma level in diabetics with potency disorders Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 1064-1067Cacciari, E.; Cicognani, A.; Tassoni, P.; Flamigni, P.; Bolelli, F.; Pirazzoli, P.; Salardi, S. 1974: Plasma testosterone and estradiol concentration in prepubertal boys with cryptorchidism before and after dexamethasone and after human chorionic gonadotropin administration Helvetica Paediatrica Acta 29(1): 27-34
Katsiia, G.V.; Chirkov, A.M.; Goncharov, N.P. 1984: Effect of luliberin and chorionic gonadotropin on luteinizing hormone and testosterone levels in the blood of monkeys under acute stress Problemy Endokrinologii 30(1): 73-77
Barták, V.; Skrha, F. 1978: Spermiograms in diabetics without potency disorders Casopis Lekaru Ceskych 117(22-23): 711-713
Rossodivita, A.; Becerra Merchan, L.; Giordano, P.; Latella, C.; Chiaretti, A.; Colabucci, F. 1996: Response of testosterone to chorionic gonadotropin stimulus in prepubertal cryptorchidism and retractile testes. Age-related changes in gonadal steroidogenesis. Authors'experience Minerva Pediatrica 48(10): 439-443
Vácha, K.; Fabián, M.; Kopecný, J. 1971: Value of immunological determination of the HCG-(human chorionic gonadotropin) level in hydatiform mole Zentralblatt für Gynakologie 93(37): 1289-1292
Hwang, D.; Hancock, B.W. 2004: Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases Journal of Reproductive Medicine 49(7): 559-562
Secreto, G.; Recchione, C.; Fariselli, G.; Grignolio, E.; Di Pietro, S. 1984: Circulating levels and breast cyst fluid concentrations of human chorionic gonadotropin, progesterone and testosterone in women with gross cystic breast disease Tumori 70(6): 523-527
Pavía, C.; Ferrer, I.; Martín, M.R.; Martínez de Osaba, M.J.; Valls, C.; Palou, A. 1983: Response of plasma testosterone to stimulation with chorionic gonadotrophin in children and adolescents: a comparison of 2 protocols Medicina Clinica 81(15): 658-661
Barták, V.; Stárka, L.; Homolka, J.; Visnák, K. 1980: Plasma testosterone, secreted 17-ketosteroids, and qualitative characteristics of ejaculate in diabetics Casopis Lekaru Ceskych 119(17-18): 481-484
Benjapibal, M.; Wataganara, T.; Senawong, S.; Boriboonhirunsarn, D.; Suphanit, I. 2001: The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease Journal of the Medical Association of Thailand 84(7): 1000-1005
Rao, C.V.; Hussa, R.O. 1982: A simple way to determine nonspecific effects of plasma and serum components in radioreceptor assays and radioimmunoassays for human chorionic gonadotropin American Journal of Obstetrics and Gynecology 142(2): 153-158
Grazul, A.; Przała, J.; Wiesak, T.; Muszyńska, A. 1986: Oestradiol-17 beta influence on testosterone production of luteal cells from early pregnant, oestradiol benzoate-treated and human chorionic gonadotropin-treated sows in vitro Acta Veterinaria Hungarica 34(3-4): 263-269
Capitanio, G.L.; Conte, N.; Ragni, N.; Rossato, P.; Pedretti, E. 1978: Demonstration of human chorionic gonadotropin during the second half of the menstrual cycle in plasma of regularly menstruating women users of copper IUds Acta Europaea Fertilitatis 9(1): 11-19
Sas, M.; Apró, G.; Falkay, G. 1977: LH-RH loading tests in andrologic patients with hypogonadism Orvosi Hetilap 118(32): 1887-1890
Garcia, J.; Kholkute, S.D.; Dukelow, W.R. 1993: The efficacy of stored pregnant mares' serum gonadotropin and human chorionic gonadotropin on inducing ovulation in mice Laboratory Animal Science 43(2): 198-199
Dubourdieu, S.; Charbonnel, B.; Massai, M.R.; Marraoui, J.; Spitz, I.; Bouchard, P. 1991: Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration Fertility and Sterility 56(3): 440-445
Mukhopadhyay, A.; Bhatia, P.K.; Majumdar, S.S. 1998: Preliminary studies with recombinant chorionic gonadotropin beta-subunit produced in Escherichia coli for use as an antigen in a birth control vaccine American Journal of Reproductive Immunology 39(3): 172-182
Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68
Heinrichs, H.R.; Milde, K.; Junkers, K.; Heinze, V.; Burmeister, P. 1973: Plasma testosterone level of male patients during chronic hemodialysis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 734-738